oxazoles has been researched along with bms 207940 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buchhorn, R; Hulpke-Wette, M | 1 |
Barrish, JC; Bird, E; Chen, P; Chong, S; Gu, Z; Hermsmeier, M; Humphreys, WG; Koplowitz, B; Leith, L; Liu, EC; Marino, A; Mathur, A; Moreland, S; Morrison, RA; Murugesan, N; Spergel, S; Trippodo, N; Waldron, T; Webb, ML; Young, M; Zhang, R | 1 |
Donahue, S; Hughes, D; Tay, LK; Zhou, YS | 1 |
Huang, MH; Hughes, DE; Macor, JE; Shi, Y | 1 |
Dannals, RF; Hilton, J; Mathews, WB; Murugesan, N; Ravert, HT; Scheffel, U; Szabo, Z; Xia, J | 1 |
1 review(s) available for oxazoles and bms 207940
Article | Year |
---|---|
BMS-193884 and BMS-207940 Bristol-Myers Squibb.
Topics: Animals; Clinical Trials as Topic; Drug Industry; Endothelin Receptor Antagonists; Heart Failure; Humans; Hypertension, Pulmonary; Oxazoles; Sulfonamides | 2002 |
4 other study(ies) available for oxazoles and bms 207940
Article | Year |
---|---|
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective
Topics: Administration, Oral; Animals; Blood Pressure; Caco-2 Cells; Carotid Arteries; CHO Cells; Cricetinae; Endothelin Receptor Antagonists; Humans; In Vitro Techniques; Isoxazoles; Macaca fascicularis; Male; Muscle Contraction; Oxazoles; Rabbits; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Structure-Activity Relationship; Sulfonamides | 2003 |
Simulation of the impact of atropisomer interconversion on plasma exposure of atropisomers of an endothelin receptor antagonist.
Topics: Administration, Oral; Area Under Curve; Crystallography, X-Ray; Endothelin Receptor Antagonists; Half-Life; Humans; Injections, Intravenous; Metabolic Clearance Rate; Oxazoles; Stereoisomerism; Sulfonamides | 2004 |
Characterization of the in vitro atropisomeric interconversion rates of an endothelin A antagonist by enantioselective liquid chromatography.
Topics: Biphenyl Compounds; Blood Proteins; Chromatography, High Pressure Liquid; Endothelin A Receptor Antagonists; Half-Life; Humans; Kinetics; Lasers; Molecular Conformation; Oxazoles; Spectrophotometry, Ultraviolet; Stereoisomerism; Sulfonamides | 2005 |
Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
Topics: Animals; Benzamides; Carbon Radioisotopes; Endothelin A Receptor Antagonists; Fluorine Radioisotopes; Isotope Labeling; Ligands; Male; Metabolic Clearance Rate; Mice; Molecular Probe Techniques; Organ Specificity; Oxazoles; Papio; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Endothelin A; Sulfonamides; Tissue Distribution | 2008 |